Skip to main content
. 2020 Dec 11;55(Suppl 1):181–714. doi: 10.1038/s41409-020-01120-w
Outcomes Non-cryopreserved(n=26) Cryopreserved(n=16) P value
Time to neutrophil engraftment (days) -- median (range) 12 (10-19) 10.5 (8-20) 0.203
Time to platelet engraftment (days) -- median (range) 14 (10-23) 12 (10-31) 0.809
Incidence of graft failure -- no. (%) 0 0 1.000
Transplant-related mortality -- no. (%) 1 (3.8) 0 0.619
CD34+ cell dose (x106 cells/kg) -- median (range) 3.8 (2.0-16.5) 4.7 (2.3-29.1) 0.062
CD34+ cell viability (%) -- median (range) 98.5 (94-99) 93.5 (70-98) <0.001
Stem cells infusion reactions -- no. (%) 5 (19.2) 6 (37.5) 0.172
Total days of hospitalization -- median (range) 25.5 (18-30) 33 (17-55) 0.002
Total cost of ASCT (in 1,000 THB) -- mean ± SD 340.5 ± 75.8 377.7 ± 159.8 0.394